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Abstract
Arabidopsis thaliana CENTRIN2 (AtCEN2) has been shown to modulate Nucleotide Excision Repair
(NER) and Homologous Recombination (HR). The present study provides evidence that AtCEN2 inter-
acts with the Arabidopsis homolog of human XPC, AtRAD4 and that the distal EF-hand Ca2+ binding
domain is essential for this interaction. In addition, the synthesis-dependent repair efﬁciency of bulky DNA
lesions was enhanced in cell extracts prepared from Arabidopsis plants overexpressing the full length
AtCEN2 but not in those overexpressing a truncated AtCEN2 form, suggesting a role for the distal EF-
hand Ca2+ binding domain in the early step of the NER process. Upon UV-C treatment the AtCEN2
protein was shown to be increased in concentration and to be localised in the nucleus rapidly. Taken
together these data suggest that AtCEN2 is a part of the AtRAD4 recognition complex and that this
interaction is required for efﬁcient NER. In addition, NER and HR appear to be differentially modulated
upon exposure of plants to DNA damaging agents. This suggests in plants, that processing of bulky DNA
lesions highly depends on the excision repair efﬁciency, especially the recognition step, thus inﬂuencing the
recombinational repair pathway.
Abbreviations: BER, Base Excision Repair; DSB, Double Strand Break; GFP, Green Fluorescent Protein;
HR, Homologous Recombination; ICL, Inter/Intra Crosslink; NHEJ, Non Homologous End Joining;
NER, Nucleotide Excision Repair; MMR, Mismatch Repair; XP, Xeroderma Pigmentosum
Introduction
The Centrin protein family is highly conserved
from yeast to humans and is closely related to the
EF-hand Ca2+-binding domain calmodulin family
(Salisbury, 1995). AtCEN2 is very similar to the
HsCEN2 protein with 55.8% identity and 71.2%
similarity within their EF-hand domains (Molinier
et al., 2004). AtCEN2 defective Arabidopsis plants
are hypersensitive to UV-C and exhibit a reduced
eﬃciency of DNA synthesis-dependent repair of
UV induced DNA damage (Molinier et al., 2004).
This repair defect is accompanied by enhanced
levels of somatic homologous recombination
(HR). These observations led to the proposal that
AtCEN2 is involved in the NER process and that
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a novel interconnection between an early step of
NER and HR exists in Arabidopsis (Molinier
et al., 2004).
Nucleotide Excision Repair (NER) machinery
recognises a wide range of bulky DNA lesions
including damage formed after UV irradiation and
treatment with anti-cancer drugs such as Cisplatin
and Mitomycin C (for review Costa et al., 2003).
The NER process consists of 5 steps: the recogni-
tion of the DNA damage, the opening of the pre-
incision complex, the dual incision of the lesion,
the DNA synthesis followed by the ligation of the
newly synthetised DNA strand.
In animal models, defects in NER have been
linked to genetic disorders, such as Xeroderma
Pigmentosum (XP). Seven XP-genes (XPA-G)
with distinct functions in repair have been identi-
ﬁed (de Laat et al., 1999). A complex consisting of
XPC/hHRad23B (XPC and human homolog of
Rad23) has been documented to be of critical
importance for recognition of DNA adducts (Hey
et al., 2002). Puriﬁcation of the XPC complex
from Hela cells revealed the existence of a third
component, CENTRIN2 (HsCEN2), a Ca2+-
binding protein with four EF-hand domains
(Araki et al., 2001). The human CEN2 (HsCEN2)
and XPC proteins have been shown to directly
interact and it has been suggested that HsCEN2
may stabilise the XPC/hHRad23B complex. Re-
cently Nishi et al. (2005) have shown that
HsCEN2 stimulates NER by interacting with the
C-terminal region of XPC.
DNA double-strand break (DSB) can also
occur in the cell. HR is the major DNA DSB
repair process in yeast, whereas non-homologous-
end joining (NHEJ) is preferentially used in higher
eukaryotes for repairing DSBs (Puchta and Hohn,
1996; Vonarx et al., 1998; Britt, 1999; Elliott and
Jasin, 2001). The level of HR-dependent repair is
affected by defects in NER, as well as in Base
Excision Repair (BER) and Mismatch Repair
(MMR) in all analysed eukaryotic organisms
suggesting the existence of interconnections be-
tween these different repair pathways (Liang et al.,
1998; Paques and Haber, 1999; Ries et al., 2000;
Elliott and Jasin, 2001; Gherbi et al., 2001; Hen-
dricks et al., 2002; Villemure et al., 2003; Dubest
et al., 2004; Molinier et al., 2004). NER has also
been shown to be the initial step in repair of inter/
intrastrand crosslinks repair (ICLs), followed by
recombinational DNA repair (Cole and Sinden,
1975; Jachymczyk et al., 1981; De Silva et al.,
2000; Saffran et al., 2004).
We used biochemical and genetic approaches to
analyse the role of AtCEN2 protein in DNA repair
and to test the interconnection between NER and
recombinational DNA repair. We show that
AtCEN2 interacts with the Arabidopsis homolog
of human XPC (AtRAD4) in a Ca2+ dependent
manner and that the distal EF-hand domain of
AtCEN2 is required for this interaction. Poly-
clonal antibodies raised against recombinant
AtCEN2 were used to show that the AtCEN2
protein concentration increased rapidly upon
UV-C exposure. Following UV-C treatment a
functional AtCEN2–GFP fusion protein localised
rapidly in the nucleus. The efﬁciency of DNA
synthesis-dependent repair of UV-C and Cisplatin
induced DNA damage, known to be predomi-
nantly repaired by the NER pathway, was en-
hanced in Arabidopsis plants overexpressing the
full length AtCEN2 as compared to wild type. In
contrast, plants overexpressing a truncated
AtCEN2 form did not show any differences in
synthesis-dependent repair compared to the con-
trol. The rate of recombinational DNA repair was
found to be low in plants overexpressing the full-
length AtCEN2 after treatments with UV-C and
Cisplatin whereas HR frequency (HRF) was
strongly stimulated in control and plants overex-
pressing a truncated AtCEN2 form. We therefore
suggest that bulky DNA lesions are processed in a
different way depending on the efﬁciency of the
NER pathway.
Materials and methods
Protein puriﬁcation, antibodies and western blotting
The cDNAs of full length AtCEN2 (At4g37010),
truncated AtCEN2-C (nucleotides 1 to 432) or
AtCEN2-B (nucleotides 1 to 324) were cloned into
pGEX3X plasmid (Amersham Biosciences, Eng-
land) in order to produce GST protein fusions.
These fusion proteins were expressed in E. coli
strain Bl21 and puriﬁed on glutathione-sepharose
4B (Amersham Biosciences, England) according to
manufacturerO˜s instruction. Proteins CEN2,
CEN2-C, and CEN2-B were cleaved from GST by
factor Xa (Amersham Biosciences, England) and
the protein purity was analysed by SDS-PAGE.
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AtCEN2 was used to raise polyclonal antibody in
rabbit (a-CEN; commercially made by Eurogentec,
Belgium). For western blot analysis, plants were
ground in liquid nitrogen, Laemmli SDS sample
buﬀer (10% glycerol, 2% SDS, 60 mM Tris–HCl
pH 6.8, 2% b-mercaptoethanol, and 0.005% brom-
ophenol blue) was added, vigorously mixed for 30–
60 s and incubated for 8 min at 95 C. Cell debris
were removed by centrifugation in a benchtop
centrifuge and the supernatant was used for protein
analysis. Ten lg of proteins were loaded onto 15%
acrylamide-containing SDS gel, and proteins were
fractionated by electrophoresis. Proteins were then
transferred to nitrocellulose membrane. A dilution
of 1:1000 of the a-CEN polyclonal rabbit antibody
was used for the western blot. The ECL detection
kit was used for chemiluminescence detection
(Amersham Biosciences, England).
In vitro translation and protein–protein interaction
The cDNA of the C-terminal AtRad4 (At5g16630;
last 852 nucleotides) was cloned into plasmid
pPET3d. TNT T7-coupled transcription/transla-
tion system (Promega, Switzerland) and [35S]
Methionine (Amersham Biosciences, England)
were used for the in vitro translation of [35S]-
labelled Rad4-Ct. T7 Luciferase (LUC) DNA
provided by the manufacturer (Promega, Switzer-
land) was used as a control. [35S]-labeled proteins
were checked on SDS-PAGE, followed by autora-
diography. To analyse protein–protein interaction
in vitro, [35S]-Rad4-Ct or [35S]-LUC was incubated
with GST-CEN2 or-CEN2-C or CEN2-B on glu-
tathione-sepharose 4B in buffer A (20 mM potas-
sium phosphate (pH 7.5), 100 mM potassium
chloride, 10% glycerol, 0.01% Triton X-100,
1 mM DTT, 1 mM CaCl2, and complete protease
inhibitor tablet without EDTA (Roche Applied
Science, Switzerland) or buffer B (buffer A without
CaCl2 but with 1 mM EGTA). The incubation was
performed at 4 C for 2 h. Beads were washed 3
times with individual buffers. Proteins were eluted
from the beads with one volume of 2SDS sample
buffer and analysed on 12% SDS-PAGE, followed
by autoradiography.
Production of transgenic plants
The pOEX4 vector (Molinier et al., 2004) con-
taining the mas (mannopine synthase) promoter
was used to drive the expression of either the full
length AtCEN2 or the truncated AtCEN2-C
cDNA into Arabidopsis plants. Arabidopsis IC9
line carrying the intermolecular recombination
substrate (Molinier et al., 2004) were used to
produce AtCEN2 or AtCEN2-C overexpressing
plants. T3 homozygous transgenic plants were
used to monitore somatic homologous recombi-
nation frequency.
The same binary vector was used to drive the
expression of a GFP-AtCEN2 protein fusion
(C-terminus fusion of the E-GFP, Clontech) and
used to transform WT Arabidopsis plants (ecotype
Columbia). T3 homozygous transgenic plants were
used for further experiments.
The pLOLA vector containing the double 35S
promoter, the myc coding sequence and the nos
terminator (Ferrando et al., 2001) was used to
create the AtCEN2 C-terminus myc tagged fusion
protein. The AtCEN2 cDNA was cloned between
the NcoI–HindIII sites. In order to produced
transgenic Arabidopsis plant, the double 35S
promoter-coding sequence, AtCEN2 cDNA, myc
sequence and terminator were subcloned into the
KpnI site of the pOEX6N binary vector (Fritsch,
unpublished). This plasmid was mobilised into
Agrobacterium tumefaciens and used to transform
WT Arabidopsis plants (ecotype Columbia). T3
homozygous transgenic plants were used for futher
experiments.
AtCEN2 knock-out and AtCEN2 RNAi Ara-
bidopsis plants used in the present study have been
described in Molinier et al. (2004).
DNA damage treatments and determination
of somatic homologous recombination
frequency (HRF)
For all experiments plants were grown in vitro on
solid GM medium (MS elements [Duchefa, The
Netherlands], 1% sucrose, 0.8% agar [Agar-agar
Ultrapur, Merck], pH 5.8) in a culture chamber
under a 16/8 h photoperiod (24/21 C) during
7 days or 13 days before being subjected to the
speciﬁc preculture condition established for each
treatment For UV-C treatment, 7-day-old plants
were transferred to large Petri dishes (160 mm
diameter) containing solid GM medium, to a
density of 1 plant/cm2 and grown for an additional
week. For the UV-C irradiation (254 nm, 6 Kerg/
cm2) a Mineral light-Lamp (UV-Products Inc.,
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San Gabriel, USA) was used. For the Cisplatin
treatment 13-day-old plants were subcultured
during 24 h in 300 ll of liquid GM medium in
24 cell plates. Before treatment the culture medium
was removed and Cisplatin (0, 1 and 5 lM, Sigma,
Buchs, Switzerland) diluted in liquid GM medium
was applied.
Somatic HRF was measured in the T3 gener-
ation of 2-week-old plants in a batch of 24 plants
after treatments with either UV-C (0, 10, 30 and
50 Kerg/cm2) or Cisplatin (0, 1 and 5 lM). We
deﬁne HRF as the average number of GUS+
spots (recombination events) per plant. Experi-
ments were duplicated.
Microscopy
Roots of vertically grown one-week old in vitro
germinated plants were irradiated with UV-C at
10 Kergs/cm2 using a Minerallight-Lamp (UV-
Products, San Gabriel, CA) and left to recover in a
growth chamber for a period of 30 min or 1 h or
2 h before imaging. For Cisplatin treatment one-
week old in vitro germinated plants were subcul-
tured in 500 ll of liquid GM medium during 24 h.
Before treatment the culture medium was removed
and Cisplatin (1 lM) diluted in liquid GM
medium was applied. Plants were cultured in a
growth chamber for a period of 1 h, 2 h or 4 h
before imaging. Images were captured as a stacked
series using Olympus Fluoview BX61 laser Scan-
ning confocal microscope and processed using
Adobe Photoshop.
In vitro DNA repair assay
The in vitro repair assay according the method
described by Li et al. (2002) was performed on cell
extracts prepared from AtCEN2, AtCEN2-C
overexpressing plants and from the IC9 line as
control. The pGEX and pBSK plasmids were
linearised using the SmaI restriction enzyme and
puriﬁed using the Gel extraction kit (Qiagen,
Germany). The pGEX-linearised plasmid was
either UV-C damaged (450 J/m2) using the Strat-
alinker (Stratagene) or Cisplatin damaged (5 lM)
according Li et al. (2002) and used as repair
substrate. The non-damaged pBSK-linearised
plasmid was used as internal control. Twenty-ﬁve
lg of protein extracts were used per time point and
mixed with 200 ng of damaged plasmid (pGEX)
and 300 ng of non-damaged plasmid (pBSK). The
reaction was stopped 1 or 2 h after incubation.
Plasmids were puriﬁed using the Gel extraction kit
(Qiagen, Germany) and separate by electrophore-
sis on a 0.8% agarose gel. DNA was transferred to
a nylon membrane (Roche, Manheim, Germany)
by capillary transfer and DIG detection proce-
dures were performed using the DIG Nucleic Acid
Detection kit (Roche, Manheim, Germany)
according the manufacturer’s instruction. The
Quantitity One software (Biorad, France) was
used to normalise the loading of the plasmid and
the DIG detection signal relative to the non-
damaged control plasmid. The synthesis-depen-
dent repair efﬁciency from cell extracts of AtCEN2
and AtCEN2-C overexpressing plants was calcu-
lated relative to this control.
Results
Characterisation of AtCEN2 expression
In order to analyse the biological function of
AtCEN2 in DNA repair, polyclonal antibodies
were raised against a puriﬁed recombinant At-
CEN2 protein. Anti-AtCEN2 serum recognised
the puriﬁed protein whereas the pre-immune
serum did not (Figure 1A). In wild type plants
AtCEN2 was detectable at the expected molecular
weight of 20 kDa (Figure 1B). The protein could
not be detected in plants defective for AtCEN2
expression (Molinier et al., 2004) proving the
speciﬁcity of the anti-AtCEN2 antibody and the
absence of crossreactivity with the endogenous
AtCEN1 protein (Figure 1B). The antibody also
reacted to epitope-tagged AtCEN2 proteins, such
as AtCEN2-GFP and AtCEN2-Myc, expressed in
plants (Figure 1C). It has previously been shown
that the steady state level of AtCEN2 mRNA
increased 2 h after UV-C treatment (Molinier
et al., 2004). This antiserum has now permitted
us to determine whether or not the AtCEN2
protein content varies in response to DNA dam-
age. The AtCEN2 protein level increased more
than 3 fold 30 min after exposure to UV-C and
remained constant up to 6 h after UV irradiation
(Figure 1D). This rapid increase of AtCEN2
content may reﬂect an important role for this
protein in the early response to UV irradiation. In
contrast, in plants treated with bleomycin (BLM),
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a commonly used anti-cancer drug causing pre-
dominantly DSBs, the steady state levels of At-
CEN2 mRNA and protein do not change (data
not shown). AtCEN2 transcript and protein levels
thus speciﬁcally respond to UV-C induced DNA
damage.
AtCEN2 localises in the nucleus after exposure
to UV-C and Cisplatin
In order to study the subcellular localisation of
AtCEN2, E-GFP was fused to its C-terminus.
Arabidopsis plants overexpressing AtCEN2-GFP
under the control of a constitutive promoter were
produced and characterised (Figure 1C). Their
ability to repair UV damaged DNA using an
in vitro DNA repair assay was evaluated. Similarly
to plants overexpressing a non-tagged AtCEN2
(Molinier et al., 2004), AtCEN2-GFP plants ex-
hibit higher synthesis-dependent repair of UV-C
induced DNA damage compared to wildtype (data
not shown), conﬁrming that the CEN2-GFP
fusion is biologically functional and can therefore
be used to analyse the intracellular dynamics of
AtCEN2 after exposure to various DNA damag-
ing agents such as UV-C and Cisplatin. These
analyses were done in roots as the repair of bulky
DNA lesions in this tissue is predominantly
through the NER pathway (Kimura et al., 2004).
In untreated roots, the GFP ﬂuorescence was
relatively low and mostly localised in the cyto-
plasm (Figure 2A and D). After exposure to UV-C
(30 min) and Cisplatin (2 h), GFP ﬂuorescence
was localised in the nuclei of roots cells and hairs
roots, respectively (Figure 2B, C and E).
AtCEN2 interacts with the Arabidopsis homolog
of human XPC (AtRad4)
Mammalian CEN2 has been shown to bind to the
XPC/hHRAD23B complex (Araki et al., 2001). In
order to investigate whether AtCEN2 binds to the
Figure 1. Characterisation of AtCEN2 expression using polyclonal anti-AtCEN2 antibodies. (A) Immunoblot analysis of the puri-
ﬁed AtCEN2 protein using pre-immune (PI) and immune (I) sera. The immune serum is able to recognise the puriﬁed AtCEN2
protein at 20 kDa. (B) Immunoblot analysis of AtCEN2 protein of wild type (AtCEN2 +/+), knock-out (AtCEN2 )/)) and At-
CEN2 RNAi plant cell extracts (See experimental procedures for details). Comassie blue staining was used as loading control. (C)
Immunoblot analysis of AtCEN2 protein level in plant overexpressing either a GFP or myc tagged fusion. Endogenous AtCEN2 is
detectable at 20 kDa. (D) Immunoblot analysis of AtCEN2 protein of WT plant cell extracts after treatment with UV-C (10 Kerg/
cm2). Comassie blue staining of the Rubisco was used as loading control.
349
Arabidopsis homolog of human XPC, AtRad4, an
in vitro aﬃnity pull-down assay was used.
Recombinant GST-AtCEN2 fusion protein was
produced, puriﬁed and coupled onto glutathione-
sepharose beads. The part of the AtRad4 gene
coding for the conserved C-terminal domain, has
been shown to interact with HsCEN2 (Popescu
et al., 2003) was cloned and the protein was
radioactively labeled with 35S-Met using an in vitro
transcription-coupled translation kit. In the pres-
ence of 1 mM of Ca2+, 35S-AtRad4-Ct bound to
GST-CEN2, as proven by the single band detected
after elution (Figure 3A). In contrast, in the
presence of 1 mM of EGTA this interaction was
signiﬁcantly reduced (Figure 3A). 35S-labeled
luciferase used as control did not show any
binding (Figure 3A). These data show that the
Arabidopsis CENTRIN2 binds the homolog of
the human XPC, AtRad4 and that calcium is
required for this interaction.
In order to map the AtRad4-binding site in
AtCEN2, truncated versions of GST-CEN2 were
produced and puriﬁed (Figure 3B). In CEN2-C,
the distal EF-hand domain was removed and in
GST-CEN2-B, the two C-terminal EF-hand
domains were deleted (Figure 3B). Only the full
length CEN2, but neither of the truncated forms
were able to bind to Rad4-Ct (Figure 3C).
35S-labeled luciferase did not show binding to
any of these CEN2 proteins, neither the full-length
nor the truncated AtCEN2 forms, conﬁrming the
speciﬁcity of the binding (Figure 3D). These data
suggest that the C-terminal EF-hand domain of
CEN2 is critically required for its binding to
AtRad4, an interaction which may stabilise the
damage recognition complex AtRAD4/AtRAD23.
The distal EF-hand domain of AtCEN2
is required for eﬃcient NER
It has previously been shown that AtCEN2 defec-
tive plants exhibit moderate UV-C sensitivity
(Molinier et al., 2004) and it may thus be expected
to observe a higher tolerance to UV irradiation in
AtCEN2 overexpressing plants. However, neither
plants overexpressing the full length AtCEN2 nor
those overexpressing the truncated form of At-
CEN2 exhibited signiﬁcant altered sensitivity to
UV-C and Cisplatin treatments as compared to the
control plants (data not shown). AtCEN2 protein
concentration is thus not a limiting factor for UV
and Cisplatin tolerance.
In order to more directly test the implication of
AtCEN2 in DNA repair the repair efﬁciency of
bulky DNA damage such as UV-C and Cisplatin
was evaluated using an in vitro repair assay. This
assay evaluates the excision repair eﬃciency of
plant cell extracts by measuring the eﬃciency of
Figure 2. Subcellular localisation of a constitutively expressed AtCEN2-GFP fusion upon UV-C and Cisplatin treatments in Ara-
bidopsis root cells. The AtCEN2-GFP fusion protein was stably expressed in transgenic Arabidopsis plants (see materials and
methods for details). Weak ﬂuorescence was observed in roots which were untreated (A and D), 30 min following UV-C irradia-
tion (B and C, 10 Kerg/cm2) or 2 h following Cisplatin treatment (E, 1 lM). These pictures are representatives of 3 independent
experiments. Size bars represent: 75 lm (A), 50 lm (B and C), 100 lm (D and E).
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incorporation of DIG dUTP in a UV-C or
Cisplatin damaged plasmid. Thereby the eﬃciency
of dark repair of UV-C and Cisplatin induced
DNA damage is evaluated for plants overexpress-
ing the full-length and truncated AtCEN2 forms.
DNA synthesis-dependent repair of both UV-C
and Cisplatin damage was more efﬁcient in plants
overexpressing the full length AtCEN2 compared
to the control (Figure 4). In contrast no signiﬁcant
change in the repair efﬁciency was observed in
Figure 4. In vitro synthesis-dependent repair eﬃciencies of UV-C and Cisplatin induced DNA damage of cell extracts from
AtCEN2, AtCEN2-C overexpressing plants. Synthesis-dependent repair eﬃciencies (%) of AtCEN2 and AtCEN2-C overexpressing
plants are expressed relative to the untreated plasmid control 1 and 2 h after incubation (See materials and methods for details).
Figure 3. In vitro binding assay of AtCEN2 with the C-terminal domain of AtRad4. (A) In vitro binding of AtCEN2 with AtRad4.
The binding assay was performed using [35S]-labelled Rad4 and GST-CEN2 in the presence of Ca2+ or EGTA (see experimental
procedures for details). The [35S]-labelled luciferase (LUC) was used as control. (B) Schematic representation of the different
AtCEN2 forms: full length AtCEN2; AtCEN-C with deletion of the distal EF-hand domain, AtCEN-B with deletion of the
C-terminal 2 EF-hand domains. Red box: ATP-binding site; blue box: EF-hand domain. SDS PAGE gel (15%) of recombinant
truncated forms of AtCEN2. (C) In vitro binding assay of the diﬀerent AtCEN2 forms with AtRad4 in the presence of Ca2+. (D)
Control of the in vitro binding assay using the luciferase protein.
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plants overexpressing the AtCEN2-C form com-
pared to the control (Figure 4). These data suggest
that the distal EF-hand domain of AtCEN2, via its
interaction with AtRad4, contributes to improve
the NER efﬁciency and that this interaction is a
limiting factor for the DNA synthesis-dependent
repair of UV and Cisplatin induced DNA damage
as measured in vitro. In addition, these results may
allow the conclusion that in plants the AtRad4
complex is also involved in the synthesis dependent
repair of bulky DNA lesions such as ICL.
Recombinational DNA repair is not or is weakly
stimulated in plants overexpressing AtCEN2
In a previous study we have shown that plants
deﬁcient for AtCEN2 expression exhibited a
reduced eﬃciency in synthesis dependent repair
of UV lesions accompanied by an increased
somatic HR frequency (Molinier et al., 2004).
These results had suggested the existence of an
interconnection between different DNA repair
pathways (i.e. NER and HR). Therefore we
addressed the question whether up-regulated syn-
thesis-dependent repair of bulky DNA lesions
could inﬂuence recombinational DNA repair.
For this, somatic HR was measured in transgenic
plants harbouring a recombination substrate con-
sisting of tandem disrupted b-glucuronidase
(GUS) reporter gene in direct repeat orientation
(Molinier et al., 2004). Recombination event
between the homologous sequences leads to the
restoration of an active b-glucuronidase gene and
can be monitored using a histochemical assay.
These recombination lines have been transformed
to overexpress either the full length AtCEN2 or
the truncated AtCEN2-C form.
UV-C is known to induce DNA lesions pre-
dominantly repaired by the NER pathway but it
also induces somatic HR. Cisplatin induces ICLs,
which in eukaryotes are known to be repaired by
a combination of NER and the HR pathways.
Somatic HR was found to be induced in con-
trol and 3 independent AtCEN2-C overexpressing
plants upon exposure to UV-C and Cisplatin
whereas somatic HR was not or only weakly
stimulated in 2 independent AtCEN2 overexpress-
ing plants (Figure 5A, B, D and E). Consistent
with previous ﬁndings (Molinier et al., 2004)
plants deﬁcient for AtCEN2 expression exhibited
elevated somatic HRF as compared to the control
(Figure 5C and F) both in the absence and in the
presence of induced DNA damage. It is important
to notice that a relative high difference of somatic
HRF exists between UV-C untreated and Cis-
platin untreated Atcen2 plants. This variability,
strictly restricted to AtCEN2 defective plants, is
due to the preculture conditions, which are in solid
culture medium prior UV-C exposure and in liquid
culture medium prior Cisplatin treatment.
Taken together these results show that in plants
which overexpress AtCEN2 and thus show en-
hanced synthesis-dependent repair of bulky DNA
damage, the use of somatic HR pathway is
accordingly reduced.
Discussion
Using biochemical approach we showed that
AtCEN2 interacts with the Arabidopsis homolog
of human XPC, AtRAD4 and that its distal EF-
hand Ca2+ binding domain is essential for this
interaction as well as for an efﬁcient synthesis-
dependent repair of bulky DNA lesions. In addi-
tion, the rapid nuclear localisation of AtCEN2
upon UV-C exposure strengthens its role in the
early step of the excision repair process as a
component of the plant recognition complex.
Finally we showed that AtCEN2 expression level,
modulating the NER pathway, differentially inﬂu-
ences HR efﬁciency, suggesting that interconnec-
tion between these 2 repair pathways exists.
CENTRIN2 interacts with the Arabidopsis
homolog of the human XPC protein (AtRad4)
AtCEN2 is closely related to human CEN2
(HsCEN2) with more than 70% similarity within
their EF-hand domains (Molinier et al., 2004).
The C-terminal half of HsCEN2 shows high
afﬁnity to Ca2+ and is able to form dimers and
oligomers (Durussel et al., 2000; Matei et al.,
2003). Binding of Ca2+ to the distal EF-hand
domain of HsCEN2 stabilises the protein and
induces co-operative Ca2+ binding by the 3rd EF-
hand (Matei et al., 2003). In the present study it
was not possible to distinguish whether a dimer-
isation and/or Ca2+-binding activity of AtCEN2
is/are required for its binding to AtRAD4. The
C-terminal half of HsCEN2 containing the 4th
EF-hand motif, is involved in both activities and
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AtCEN2 lacking this domain is unable to form
dimers (our unpublished data). A recent study has
also shown that reversible HsCEN2 self-assembly
depends upon its N-terminal part (Tourbez et al.,
2004). Although EF-hand domains are identical
within the centrin superfamily, AtCEN2 differs
from other members by a speciﬁc N-terminal ATP
binding domain. This domain is able to bind ATP
in the presence of EGTA but not of Ca2+,
suggesting the existence of another or a plant
speciﬁc function of the Arabidopsis CEN2 protein
(Liang, unpublished data).
HsCEN2 binds the Rad4 domain of the XPC
protein (Popescu et al., 2003). The C-terminal
domain (Rad4 domain) of XPC is well conserved
between species and contains predicted DNA,
Rad23 and TFIIH binding sites (Uchida et al.,
2002). Recently, Nishi et al. (2005) have shown
that HsCEN2 binds to a putative alpha-helical
region near the C-terminus, and that 3 amino acid
substitutions in this domain abrogated this XPC-
HsCEN2 interaction. The CEN2 binding motif is
also present in AtRad4 (Popescu et al., 2003) and
this has permitted analysis of the interaction
between the AtCEN2 and AtRad4 proteins. As
predicated, the AtCEN2 is able to bind AtRad4 in
the presence of calcium in agreement with the
work of Popescu et al. (2003) showing that
HsCEN2-XPC interaction is Ca2+-dependent.
Although the CEN2 binding domain of the XPC
Figure 5. Somatic homologous recombination frequencies (HRF) in independent transgenic plants overexpressing either the full
length AtCEN2 (OECEN1, OECEN2; A and D), the truncated AtCEN2-C form (CENC1, CENC2, CENC3; B and E) or in
AtCEN2 (C and F) deﬁcient plants upon exposure to UV-C (A, B and C) and Cisplatin (D, E and F). Plants were treated with
either UV-C (0, 10, 30 and 50 kerg/cm2) or Cisplatin (0, 1 and 5 lM). Somatic HRF±SD (average number of GUS+ spots/plant)
was determined 4 days after each treatment. 24 plants per treatment were used and experiments were duplicated.
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protein is well characterised in human nothing was
known about the CEN2 domain required for this
interaction. We show here that the distal EF-hand
domain is absolutely required for AtCEN2-
AtRad4 interaction suggesting that this domain
may also be involved for the interaction of XPC-
CEN2 in human. Thus the XPC-CEN2 binding
motif, AtRad4-AtCEN2 in this study, is conserved
between animals and plants and the recognition
complex of UV damage may be comparable in
plants as in human and may work in a similar way
in higher eukaryotes.
XPC/Rad4 protein complex stability also
requires Rad23 function, which prevents ubiqu-
itin-dependent degradation (Okuda et al., 2004).
In mouse HRad23A/B double knockout ﬁbro-
blasts, XPC protein was very unstable (Ng et al.,
2003; Okuda et al., 2004). In Arabidopsis 4
AtRad23 genes are present, but the corresponding
AtRAD4 interactor has not been identiﬁed yet. In
addition, HsCEN2 has been shown to play a role
in stabilisation of XPC in an HRad23-dependent
manner (Araki et al., 2001). XPC protein level is
low under normal growth conditions, but the
DNA repair activity of XPC can be induced upon
UV-C damage (Ng et al., 2003). We show here
that after UV-C treatment, the amount of At-
CEN2 protein increased and its subcellular local-
isation was rapidly changed. AtCEN2 relocalised
into the nucleus upon UV-C and Cisplatin treat-
ments. Consistently, XPC protein was localised to
the damage sites in mammalian cells upon UV-C
treatment (Ng et al., 2003). This suggests the
possibilities that the AtRAD4 protein is also
relocalised and stabilized at damage sites as well
as in human cells and that AtCEN2 contributes to
this process. Ng et al. (2003) have shown that
overexpression of hHRad23 leads to increased
amounts of stabilised XPC and reduced cell
viability. AtCEN2 overexpressing plants are viable
and did not exhibit developmental aberrations.
This suggests that the function of AtCEN2 is
different from those of Rad23 responsible for the
XPC stability by the regulation of proteolysis via
the ubiquitin/proteasome pathway (Schauber
et al., 1998; Ng et al., 2003). Therefore AtCEN2
may be involved in the stabilisation or stimulation
of the recognition complex at the damaged sites
without inﬂuencing signiﬁcantly AtRAD4 protein
amounts.
AtCEN2 expression level diﬀerentially inﬂuences
NER and HR eﬃciencies
In mammals the defects of the ﬁrst step of NER
(recognition step) lead to dramatic genetic disor-
ders (for review Lehmann, 2003). Rad4/XPC
deﬁcient cells exhibit higher susceptibility to bulky
DNA lesions. Although Araki et al. (2001) have
shown using in vitro appoach that HsCEN2
contributes to stabilise the XPC complex and that
the lack of HsCEN2 leads to reduced synthesis-
dependent repair eﬃciency on UV induced DNA
damage, nothing is known about the sensitivity of
CEN2 deﬁcient mammalian cells to diﬀerent DNA
damaging agents and about their recombinational
DNA repair eﬃciency. Therefore plants oﬀer a
good opportunity to study the role of CEN2 in
DNA repair. In Arabidopsis we have recently
shown that plants deﬁcient for AtCEN2 expres-
sion exhibit UV-C sensitivity, a lower NER
eﬃciency and an enhanced somatic HR frequency
(Molinier et al., 2004), suggesting an interconnec-
tion between the different repair pathways in
plants. In the present study we show that AtCEN2
overexpression leads to an increased efﬁciency of
synthesis-dependent repair of UV-C and Cisplatin
induced DNA lesions whereas overexpression of
the truncated AtCEN2-C form did not affect
repair efﬁciency.
These results also provide evidence that the
plant recognition complex, AtRad4-AtCEN2
including also AtRad23, is involved in ICL repair
as in other eukaryotes (You et al., 2003). In yeast
and mammals ICL repair requires both NER and
HR (for review Mc Hugh et al., 2001). In WT
Arabidopsis, somatic HR is induced after Cis-
platin treatment, showing that HR also contrib-
utes to ICL repair. We demonstrate here that
overexpression of AtCEN2 abolishes this en-
hanced HRF suggesting that increased capacity
of synthesis-dependent repair of bulky DNA
damage prevents recombinational repair. Recent
studies showed that the recognition complex in
general and XPC protein in particular play critical
roles in Cisplatin DNA repair initiation by pre-
venting high mutation rate (Wang et al., 2004a, b).
Our results address the question of the potential
role of CEN2 in this repair process, which is
especially relevant for cancer cell drug resistance in
mammalian cells.
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The relatively lower induction of somatic HR
in AtCEN2 overexpressing plants after treatments
with UV-C and Cisplatin suggests that critical
points for the regulation of the different repair
pathways may include connections between up-
stream recognition processes, competition of
repair factors for substrates and the state of
chromatin at the damaged sites.
Our ﬁndings are in agreement with the recent
results of Garinis et al. (2005) who have shown in
mammalian cells that UV lesions, such as cyclob-
utane pyrimidine dimers (CPDs), lead to the
accumulation of gamma-H2AX, P53bp1, Rad51
foci and increased amounts of DSBs which are
substrates for the HR process. Therefore, Arabid-
opsis plants either defective for CEN2 expression
or overexpressing CEN2 is a material of choice to
study the becoming of the UV lesions in plants
misregulated in NER and the stimulation or
inhibition of the HR process, respectively.
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